Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
33.72 USD | +0.54% | +2.91% | +51.57% |
02/05 | Agios Pharmaceuticals Shares Rise After Reporting Smaller Q1 Loss | MT |
02/05 | Transcript : Agios Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 02, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+51.57% | 1.9B | |
+4.52% | 111B | |
+10.99% | 105B | |
-11.96% | 22.34B | |
-3.76% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-9.23% | 16.96B | |
+3.17% | 13.7B | |
+36.44% | 12.45B |
- Stock Market
- Equities
- AGIO Stock
- News Agios Pharmaceuticals, Inc.
- Canaccord Genuity Adjusts Agios Pharmaceuticals' Price Target to $52 From $65, Keeps Buy Rating